1Kikuchi T, Tottori K, Uwahodo Y, et al. OPC-14597, a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity[J]. J Pharmacol Exp Ther , 1995,274( 1 ): 329-336.
2Oshiro Y, Sato S, Kurahashi N, et al. Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7- [ 4- ( 4- phenyl- 1- piperazinyl) butoxy ] 3, 4-dihydro-2 ( 1H)-quinolinone derivatives [ J ]. J Med Chem, 1998,41(5) :658-667.
3ZhaoH, ThurkaufA, Braun J, etal. Design, synthesis, and discovery of 3-piperazinyl- 3,4-dihydro-2 ( 1H)-quinolinone derivatives: a novel series of mixed dopamine D2/D4 receptor antagonists[J]. Bioorg Med Chem Lett , 2000,10(18):2119-2122.
4Oshiro Y, Sakurai Y, Sato S, et al. 3,4-dihydro-2(1H)quinolinone as a novel antidepressant drug: synthesis and pharmacology of 1-[ 3-[ 4-( 3-chlorophenyl )-1-piperazinyl ]propyl]-3, 4-dihydro-5-methoxy-2 ( 1H )-quinolinone and its derivatives[J]. J Med Chem, 2000, 43(2): 177-189.
5Bermack J E, Haddjeri N, Debonnel G, et al. Effects of the potential antidepressant OPC 14523, a combinded sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsal raphe nucleus[J]. J Pharmacol Exp Ther,2004, 310(2):578-583.
6Obrenovitch T P, Zilkha E. Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex[J]. Br J Pharmcol, 1996 , 117 (5): 931- 937.
7Schror K. The pharmacology of cilostazol[J]. Diabetes Obes Metab, 2002,4 ( Suppl 2): S 14-19.
8Koga Y, Kihara Y, Okada M, et al. 2(1H)-quinolinone derivatives as novel anti-arteriostenotic agents showing antithrombotic and anti-hyperplastic activities [ J ]. Bioorg Med Chem Lett, 1998, 8(12): 1471-1476.
9Kawasaki K, Komori K, Okazaki J, et al. Inhibition of 12( S )-hydroxyeicosatetraenoic acid ( 12-HETE ) production suppressed the intimal hyperplasia caused by poor-runoff conditions in the rabbit autologous vein grafts [ J]. J Cardiovasc Pharmacol, 2000, 36(5) :555-563.
10Nishi T, Yamamoto K, Shimizu T, et al. Studies on 2oxoquinoline derivatives as blood platelet aggregation inhibitors I . Alkyl 4-(2-oxo-1, 2, 3, 4-tetrahydro-6quinolyloxy) butyrates and related compounds [ J ]. Chem Pharm Bull, 1983,31(3) :798-810.
